Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-02-10 @ 10:37 AM
Study NCT ID:
NCT01754766
Status:
COMPLETED
Last Update Posted:
2014-02-04
First Post:
2012-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AGN-229666 for the Treatment of Allergic Conjunctivitis
Sponsor:
Allergan
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of AGN-229666 for the treatment of allergic conjunctivitis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: